Carnot Imagine’s Post

We are honored to be invited to speak at the upcoming Advanced Therapies Integrates event.  This conference is crucial in driving advancements in complex therapeutics and regenerative medicines, addressing key challenges in the industry. It will provide valuable opportunities to provide our insights and represent the MEF2C patient community and to learn and collaborate with industry leaders. #AdvancedTherapies #MEF2C #Innovation #MCHS #Rarediseaseawareness #PatientAdvocacy #AdvancedTherapiesIntegrates Life Science Integrates

Hear what Dr. Marvin, Transplant Surgeon at Geisinger Medical Center, had to say about how he uses TruGraf to help titrate immunosuppression management in this clip from the webinar: Using Gene Expression Profile Biomarkers as an Immunosuppression Guide in Post-Transplant Care. #Eurofins #KidneyTransplantation

Get our comprehensive guide to #CellandGeneTherapy bioprocesses! In our new white paper, you’ll find: - An overview of cell and gene therapies - A deep dive into stem cell and #AAV production challenges - Strategies to overcome manufacturing hurdles - Insights from industry experts Get your free download now: https://sar.to/l0sjt #SimplifyingProgress #InThisTogether #AdvancedTherapies

⌛ “It’s time to elevate the third pillar of CGT: viability” - Carl Schoellhammer In our newest Ori Spotlight podcast episode, Jason C. Foster welcomes Carl Schoellhammer, Principal & Advanced Therapies Practice Lead at DeciBio, to discuss the importance of considering viability alongside safety and efficacy in cell and gene therapies (CGTs). Schoellhammer highlights the need for scalable and decentralized manufacturing approaches to ensure the commercial viability of these advanced therapies, as well as the challenges of maintaining consistent quality in personalized medicines, and the role of enabling technologies in addressing these hurdles. 🎧 Listen on Spotify: https://lnkd.in/gmWCkpgG #IRO #TheNewStandard #AutomateBetterBiology #AccelerateProductDevelopment #ScaleYourImpact

If you weren't able to make it to our recent MND Symposium, you can learn about key highlights from the two-day event in our latest blog post, 𝑾𝒐𝒓𝒍𝒅-𝒍𝒆𝒂𝒅𝒊𝒏𝒈 𝒓𝒆𝒔𝒆𝒂𝒓𝒄𝒉𝒆𝒓𝒔 𝒈𝒂𝒕𝒉𝒆𝒓 𝒂𝒕 𝑴𝑵𝑫 𝑺𝒚𝒎𝒑𝒐𝒔𝒊𝒖𝒎: https://bit.ly/4fl5bog The article covers symposium topics from biomarkers and targeted gene therapies, through to how MND researchers are partnering with people with lived experience through The MND Research Collective. #MND #ALS #motorneuronedisease #research #symposium

In a newly-released case study, Medpace cell and gene therapy experts evaluate the safety and efficacy of an adenovirus-based gene transfer vector for treatment of non-muscle invasive bladder cancer in a phase III open label study. Download the new case study to explore successful approaches from the recent #celltherapy clinical success: https://bit.ly/3yqvTMt

Mycophenolic Acid, derived from Penicillium species, is a common selective agent used for transfected cells expressing the E. coli GPT gene.  This popular microbial metabolite can be used in immunoassays and cancer research studies. A convenient ReadyMade™ solution format is also available. Learn more: https://lnkd.in/g-JXSkXg #research #readymade #selectiveagent

🌟 Exciting Research Update! 🌟 I'm delighted to share some insights from our recent publication, where we explore the intricate workings of our cells. Our research uncovers the collaboration between two critical proteins, MLL4 (KMT2D) and TET3, revealing a new depth to gene regulation mechanisms. In our study, we discovered how a specific part of MLL4, known as the PHD6 region, binds with TET3. This interaction highlights the complex and precise nature of gene activation, opening up potential new avenues for therapeutic approaches. Understanding these molecular interactions is crucial for developing targeted treatments for diseases, including cancer, where gene regulation plays a pivotal role. I'm proud to contribute to this field and excited about the possibilities our findings could lead to. For those interested in diving deeper into our research, I invite you to read our full article here: [https://lnkd.in/gSqc64bv] #Science #Research #Innovation #Genetics #Healthcare

Join us October 3 to explore common challenges and considerations for seamless viral vector tech transfer: https://okt.to/GDyBow Freda Cuneo and Kevin Taylor, MSAT experts in upstream and downstream production with more than three decades of combined experience, join Dr. James Cody to share valuable insights and lessons learned: - Approaches to bolster your program - MSAT best practices to avoid roadblocks - Real-world case study examples Cell & Gene Therapy Insights BioInsights #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat

Lentiviruses can infect both dividing cells and non-dividing (postmitotic) cells – allowing for application in a range of studies. This feature also makes it great for introducing gene products into in vitro systems, animal models, or human patients via cell therapy. Our end-to-end Lentivirus Packaging solution can simplify your process and accelerate your research, whether it’s for Gene and Cell Therapy or Genome Engineering, by delivering transduction-ready preps in rapid turnaround time. Optimize your research: https://hubs.ly/Q02mfN3H0 #Lentivirus #ViralPackaging #GeneTherapy